Table 3 Hematologic response of eleven AA patients.
From: Umbilical cord blood infusion in the treatment of aplastic anemia: A single center prospective study
No | Age | Diagnosis | Response | CR/PR | Time to trilineage response (days) | Duration of trilineage response (months) | Follow-up (months) | Survival |
|---|---|---|---|---|---|---|---|---|
1 | 70 | SAA | NR | NR | / | / | 5 | Death |
2 | 42 | SAA | Trilineage | PR | 37 | 6 | 7 | Survival |
3 | 60 | Non-SAA | NR | NR | / | / | 7 | Survival |
4 | 67 | SAA | Trilineage | CR | 168 | 21 | 27 | Survival |
5 | 57 | Non-SAA | Trilineage | CR | 142 | 12 | 17 | Survival |
6 | 84 | SAA | Trilineage | CR | 161 | 41 | 46 | Survival |
7 | 74 | SAA | NR | NR | / | / | 3 | Death |
8 | 9 | Non-SAA | Trilineage | CR | 87 | 44 | 47 | Survival |
9 | 21 | Non-SAA | Trilineage | PR | 81 | 20 | 23 | Survival |
10 | 28 | Non-SAA | Trilineage | PR | 137 | 26 | 30 | Survival |
11 | 34 | SAA | Trilineage | CR | 18 | 37 | 37 | Survival |
